METHOD FOR TREATING OR PREVENTING THROMBOSIS USING 150 MG B.I.D. OF DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

REILLY, PAUL, A

申请号：

NZ59261509

公开号：

NZ592615A

申请日:

2009.11.10

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

592613 Disclosed herein is the use of dabigatran etexilate, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the prevention of stroke in patients suffering from atrial fibrillation wherein the patient has no risk factors for major bleeding events, wherein the use comprises the administration 5 of a dosage of >；150 mg b.i.d. to 300 mg b.i.d. of dabigatran etexilate, or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/